We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Novavax Inc | NASDAQ:NVAX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.01 | 0.20% | 4.94 | 4.91 | 4.96 | 53,018 | 13:42:56 |
Management will host a conference call to discuss the quarterly financial results and provide an update on corporate activities.
Conference call details are as follows:
Date: | Wednesday, May 4, 2016 |
Time: | 4:30 p.m. U.S. Eastern Time (ET) |
Dial-in number: | (877) 212-6076 (Domestic) or (707) 287-9331 (International) |
Passcode: | 95870834 |
Via web: | www.novavax.com, “Investors”/ “Events” |
Conference call replay:
Dates: | Starting at 7:00 p.m. ET, May 4, 2016 until midnight May 11, 2016 |
Dial-in number: | (855) 859-2056 (Domestic) or (404) 537-3406 (International) |
Passcode: | 95870834 |
Via web: | www.novavax.com, “Investors”/ “Events” |
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.
Contact: Novavax, Inc. Barclay A. Phillips SVP, Chief Financial Officer and Treasurer Andrea N. Flynn, Ph.D. Senior Manager, Investor Relations ir@novavax.com 240-268-2000
1 Year Novavax Chart |
1 Month Novavax Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions